MICHELE YORK

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
Address7200 CAMBRIDGE
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Psychiatry & Behavioral Sciences
    DivisionPsychiatry & Behavioral Sciences


    Collapse Research 
    Collapse research activities and funding
    K23NS041254     (YORK, MICHELE KLASWICK)Apr 1, 2002 - Mar 31, 2008
    NIH
    Cognitive functioning following deep brain stimulation
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Goldman JG, Volpe D, Ellis TD, Hirsch MA, Johnson J, Wood J, Aragon A, Biundo R, Di Rocco A, Kasman GS, Iansek R, Miyasaki J, McConvey VM, Munneke M, Pinto S, St Clair KA, Toledo S, York MK, Todaro R, Yarab N, Wallock K. Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement. J Parkinsons Dis. 2024; 14(1):135-166. PMID: 38277303; PMCID: PMC10836578.
      Citations: 1     Fields:    Translation:Humans
    2. Moon S, Kletzel SL, Santos FH, Devos H, Foster ER, Goldman JG, Hirsch MA, Leroi I, Walker S, York MK. A Patient's Guide to Memory Changes in Parkinson Disease. Arch Phys Med Rehabil. 2024 Mar; 105(3):615-619. PMID: 37256244.
      Citations:    Fields:    Translation:Humans
    3. York MK, Alcalay RN. Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism Relat Disord. 2023 06; 111:105403. PMID: 37198082.
      Citations:    Fields:    Translation:Humans
    4. Stinson JM, Rom?n CAF, Combs HL, York MK, Strutt AM, McCauley SR. Geopolitical Considerations for Working with Medically Complex Patients: A Case Illustration. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):387-394. PMID: 36988412.
      Citations:    Fields:    Translation:Humans
    5. Stinson JM, Armendariz V, Hegazy MIR, Strutt AM, McCauley SR, York MK. Developing a Culturally Competent Neuropsychological Battery for Diagnosis of Dementia in Arabic-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):433-445. PMID: 36988467.
      Citations:    Fields:    Translation:Humans
    6. Qi WG, Hong Y, Sun X, Stinson JM, York MK, McCauley S, Strutt AM. A Neuropsychological Battery for the Evaluation of Dementia Among Mandarin-Speaking Older Adults in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):446-458. PMID: 36988501.
      Citations:    Fields:    Translation:Humans
    7. York MK, Kim SH, Lee DD, Windham VA, Strutt AM, Stinson JM, McCauley SR. Culturally Competent Approaches for Neuropsychological Assessment for Differential Diagnosis of Dementia of Korean-Speaking Patients in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):459-471. PMID: 36988508.
      Citations:    Fields:    Translation:Humans
    8. Henry SK, Talavari D, York MK, Stinson JM, Strutt AM, McCauley SR. Developing a Culturally Competent Neuropsychological Assessment Battery for Farsi-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):472-484. PMID: 36988547.
      Citations:    Fields:    Translation:Humans
    9. McCauley SR, Nguyen T, Nguyen C, Strutt AM, Stinson JM, Windham VA, York MK. Developing a Culturally Competent Neuropsychological Assessment Battery for Vietnamese-speaking Patients with Suspected Dementia. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):485-500. PMID: 36988566.
      Citations:    Fields:    Translation:Humans
    10. Strutt AM, Diaz Santos AL, de Minas Salerno Chiles AL, Furtado M, York MK, Stinson JM, McCauley SR. Developing Culturally Competent Foreign Language Neuropsychological Assessments: Portuguese-Speaking Brazilians Living in the United States. Arch Clin Neuropsychol. 2023 Apr 26; 38(3):501-512. PMID: 36988624.
      Citations:    Fields:    Translation:Humans
    11. Park C, Mishra RK, York MK, Enriquez A, Lindsay A, Barchard G, Vaziri A, Najafi B. Tele-Medicine Based and Self-Administered Interactive Exercise Program (Tele-Exergame) to Improve Cognition in Older Adults with Mild Cognitive Impairment or Dementia: A Feasibility, Acceptability, and Proof-of-Concept Study. Int J Environ Res Public Health. 2022 Dec 06; 19(23). PMID: 36498431; PMCID: PMC9739527.
      Citations: 1     Fields:    Translation:Humans
    12. Mishra RK, Park C, Momin AS, Rafaei NE, Kunik M, York MK, Najafi B. Care4AD: A Technology-Driven Platform for Care Coordination and Management: Acceptability Study in Dementia. Gerontology. 2023; 69(2):227-238. PMID: 36096091.
      Citations:    
    13. Lee M, Mishra RK, Momin A, El-Refaei N, Bagheri AB, York MK, Kunik ME, Derhammer M, Fatehi B, Lim J, Cole R, Barchard G, Vaziri A, Najafi B. Smart-Home Concept for Remote Monitoring of Instrumental Activities of Daily Living (IADL) in Older Adults with Cognitive Impairment: A Proof of Concept and Feasibility Study. Sensors (Basel). 2022 Sep 07; 22(18). PMID: 36146095; PMCID: PMC9501541.
      Citations:    
    14. Rothlind JC, York MK, Luo P, Carlson K, Marks WJ, Weaver FM, Stern M, Follett KA, Duda JE, Reda DJ, CSP-468 study group. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2022 02; 95:23-27. PMID: 34974395.
      Citations:    Fields:    Translation:Humans
    15. Siddiqui MS, Jimenez-Shahed J, Mari Z, Walter BL, De Jesus S, Panov F, Schwalb JM, York MK, Sarva H, Bertoni JM, Patel N, Zhang L, McInerney J, Rosenow JM. North American survey on impact of the COVID-19 pandemic shutdown on DBS care. Parkinsonism Relat Disord. 2021 11; 92:41-45. PMID: 34688029; PMCID: PMC8522505.
      Citations:    Fields:    Translation:HumansPHPublic Health
    16. Combs HL, Wyman-Chick KA, Erickson LO, York MK. Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease. Arch Clin Neuropsychol. 2021 Jul 19; 36(5):734-745. PMID: 33103727.
      Citations:    Fields:    Translation:Humans
    17. Palmese CA, Wyman-Chick KA, Racine C, Pollak LE, Lin G, Farace E, Tran B, Floden D, Bobholz J, Turner TH, York MK, Neuropsychology Focus Group of the Functional Neurosurgical Working Group (FNSWG) of the Parkinson S. Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: Lessons learned and future directions for neuropsychologists. Clin Neuropsychol. 2022 01; 36(1):72-84. PMID: 34030595.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    18. York MK, Farace E, Pollak L, Floden D, Lin G, Wyman-Chick K, Bobholz J, Palmese CA, Racine C, Tran B, Turner TH, Jimenez-Shahed J, of the Parkinson Study Group Functional Neurosurgical Working Group. The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations. Parkinsonism Relat Disord. 2021 05; 86:135-138. PMID: 34049812; PMCID: PMC8119389.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    19. Zhou H, Park C, Shahbazi M, York MK, Kunik ME, Naik AD, Najafi B. Digital Biomarkers of Cognitive Frailty: The Value of Detailed Gait Assessment Beyond Gait Speed. Gerontology. 2022; 68(2):224-233. PMID: 33971647; PMCID: PMC8578566.
      Citations: 1     Fields:    Translation:Humans
    20. Mishra R, Park C, York MK, Kunik ME, Wung SF, Naik AD, Najafi B. Decrease in Mobility during the COVID-19 Pandemic and Its Association with Increase in Depression among Older Adults: A Longitudinal Remote Mobility Monitoring Using a Wearable Sensor. Sensors (Basel). 2021 Apr 29; 21(9). PMID: 33946664; PMCID: PMC8125705.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    21. Faieta JM, Devos H, Vaduvathiriyan P, York MK, Erickson KI, Hirsch MA, Downer BG, van Wegen EEH, Wong DC, Philippou E, Negm A, Ahmadnezhad P, Krishnan S, Kahya M, Sood P, Heyn PC. Exercise interventions for older adults with Alzheimer's disease: a systematic review and meta-analysis protocol. Syst Rev. 2021 01 04; 10(1):6. PMID: 33397453; PMCID: PMC7779651.
      Citations:    
    22. York MK, Benge JF, Hunter C, Jankovic J. A validation of a self-administered screening test for Parkinson's disease. J Neurol Sci. 2020 Nov 15; 418:117116. PMID: 32919368.
      Citations:    Fields:    Translation:Humans
    23. Cerbone B, Massman PJ, Kulesz PA, Woods SP, York MK. Predictors of rate of cognitive decline in patients with amnestic mild cognitive impairment. Clin Neuropsychol. 2022 01; 36(1):138-164. PMID: 32544371.
      Citations:    
    24. Weintraub D, Caspell-Garcia C, Simuni T, Cho HR, Coffey CS, Aarsland D, Alcalay RN, Barrett MJ, Chahine LM, Eberling J, Espay AJ, Hamilton J, Hawkins KA, Leverenz J, Litvan I, Richard I, Rosenthal LS, Siderowf A, York M, Parkinson?s Progression Markers Initiative. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461. PMID: 32285645; PMCID: PMC7187707.
      Citations:    
    25. Schneider RB, Jimenez-Shahed J, Abraham DS, Thibault DP, Mantri S, Fullard M, Burack MA, Chou KL, Spindler M, Jermakowicz WJ, York MK, Kirk JC, Schwalb JM, Espay AJ, Shih LC, Simon DK, Hunter C, Crispo JAG, Willis AW, of the Parkinson Study Group Health Care Outcomes and Disparities Working Group (HCODWG) and the Reg, D'Haese PF. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis. Parkinsonism Relat Disord. 2020 01; 70:96-102. PMID: 31866156.
      Citations: 2     Fields:    Translation:Humans
    26. Cerbone B, Massman PJ, Woods SP, York MK. Benefit of phonemic cueing on confrontation naming in Alzheimer's disease. Clin Neuropsychol. 2020 02; 34(2):368-383. PMID: 31030619.
      Citations:    
    27. Driskell LD, York MK, Heyn PC, Sanjak M, MacAdam C. A Guide to Understanding the Benefits of a Multidisciplinary Team Approach to Amyotrophic Lateral Sclerosis (ALS) Treatment. Arch Phys Med Rehabil. 2019 03; 100(3):583-586. PMID: 30029769.
      Citations:    
    28. Rossetti MA, Collins RL, York MK. Performance Validity in Deep Brain Stimulation Candidates. Arch Clin Neuropsychol. 2018 Jun 01; 33(4):508-514. PMID: 28961736.
      Citations: 2     Fields:    Translation:Humans
    29. Patel N, Combs H, York M, Phan C, Jimenez-Shahed J. Pseudobulbar Affect Correlates With Mood Symptoms in Parkinsonian Disorders but Not Amyotrophic Lateral Sclerosis. J Neuropsychiatry Clin Neurosci. 2018; 30(3):214-219. PMID: 29505320.
      Citations: 3     Fields:    Translation:Humans
    30. Lotia M, York MK, Strutt AM, Jankovic J. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):692-695. PMID: 29332008.
      Citations: 1     Fields:    Translation:Humans
    31. Choudhury TK, Harris C, Crist K, Satterwhite TK, York MK. Comparative Patient Satisfaction and Feasibility of a Pilot Parkinson's Disease Enrichment Program. J Geriatr Psychiatry Neurol. 2017 Sep; 30(5):253-260. PMID: 28925334.
      Citations: 1     Fields:    Translation:Humans
    32. York MK, Moro E. No differences in neuropsychological outcomes between constant current and voltage current subthalamic deep brain stimulation for Parkinson's disease. Ann Transl Med. 2017 Apr; 5(7):177. PMID: 28480213; PMCID: PMC5401669.
      Citations: 1     
    33. Heyn PC, Hirsch MA, York MK, Backus D. Physical Activity Recommendations for the Aging Brain: A Clinician-Patient Guide. Arch Phys Med Rehabil. 2016 06; 97(6):1045-7. PMID: 27233994.
      Citations:    
    34. Bryant MS, York MK, Workman CD, Hou JG, Henson HK. Acute and Long-Term Effects of Multidirectional Treadmill Training on Gait and Balance in Parkinson Disease. PM R. 2016 12; 8(12):1151-1158. PMID: 27178378.
      Citations: 6     Fields:    Translation:Humans
    35. Jacks A, Wainwright DA, Salazar L, Grimes R, York M, Strutt AM, Shahani L, Woods SP, Hasbun R. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015 Aug 24; 29(13):1711-4. PMID: 26372282.
      Citations: 21     Fields:    Translation:Humans
    36. Calleo JS, Amspoker AB, Sarwar AI, Kunik ME, Jankovic J, Marsh L, York M, Stanley MA. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7. PMID: 26047635.
      Citations: 14     Fields:    Translation:Humans
    37. Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D, CSP-468 Study Group. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9. PMID: 25185211.
      Citations: 38     Fields:    Translation:Humans
    38. Hack N, Akbar U, Thompson-Avila A, Fayad SM, Hastings EM, Moro E, Nestor K, Ward H, York M, Okun MS. Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. J Parkinsons Dis. 2014; 4(4):591-8. PMID: 25035311.
      Citations: 7     Fields:    Translation:Humans
    39. Wiszniewski W, Hunter JV, Hanchard NA, Willer JR, Shaw C, Tian Q, Illner A, Wang X, Cheung SW, Patel A, Campbell IM, Gelowani V, Hixson P, Ester AR, Azamian MS, Potocki L, Zapata G, Hernandez PP, Ramocki MB, Santos-Cortez RL, Wang G, York MK, Justice MJ, Chu ZD, Bader PI, Omo-Griffith L, Madduri NS, Scharer G, Crawford HP, Yanatatsaneejit P, Eifert A, Kerr J, Bacino CA, Franklin AI, Goin-Kochel RP, Simpson G, Immken L, Haque ME, Stosic M, Williams MD, Morgan TM, Pruthi S, Omary R, Boyadjiev SA, Win KK, Thida A, Hurles M, Hibberd ML, Khor CC, Van Vinh Chau N, Gallagher TE, Mutirangura A, Stankiewicz P, Beaudet AL, Maletic-Savatic M, Rosenfeld JA, Shaffer LG, Davis EE, Belmont JW, Dunstan S, Simmons CP, Bonnen PE, Leal SM, Katsanis N, Lupski JR, Lalani SR. TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. Am J Hum Genet. 2013 Aug 08; 93(2):197-210. PMID: 23810381; PMCID: PMC3738832.
      Citations: 22     Fields:    Translation:HumansCells
    40. Hasbun R, Eraso J, Ramireddy S, Wainwright DA, Salazar L, Grimes R, York M, Strutt A. Screening for Neurocognitive Impairment in HIV Individuals: The Utility of the Montreal Cognitive Assessment Test. J AIDS Clin Res. 2012 Dec; 3(10):186. PMID: 23956944; PMCID: PMC3744114.
      Citations: 12     
    41. Strutt AM, Palcic J, Wager JG, Titus C, Macadam C, Brown J, Scott BM, Harati Y, Schulz PE, York MK. Cognition, behavior, and respiratory function in amyotrophic lateral sclerosis. ISRN Neurol. 2012; 2012:912123. PMID: 22852095; PMCID: PMC3407622.
      Citations: 5     
    42. Strutt AM, Ayanegui IG, Scott BM, Mahoney ML, York MK, San Miguel Montes LE. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012 Aug; 27(5):545-56. PMID: 22693138.
      Citations: 3     Fields:    Translation:Humans
    43. Marshall DF, Strutt AM, Williams AE, Simpson RK, Jankovic J, York MK. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31. PMID: 22632922.
      Citations: 11     Fields:    Translation:Humans
    44. Hou JG, Wu LJ, Moore S, Ward C, York M, Atassi F, Fincher L, Nelson N, Sarwar A, Lai EC. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012 May; 18(4):377-81. PMID: 22236581.
      Citations: 18     Fields:    Translation:Humans
    45. Armento ME, Stanley MA, Marsh L, Kunik ME, York MK, Bush AL, Calleo JS. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51. PMID: 23939438.
      Citations: 13     Fields:    Translation:Humans
    46. Calleo J, Burrows C, Levin H, Marsh L, Lai E, York MK. Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current directions. Parkinsons Dis. 2012; 2012:512892. PMID: 22135762; PMCID: PMC3216311.
      Citations: 21     
    47. Strutt AM, Scott BM, Shrestha S, York MK. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011 Oct; 25(7):1253-65. PMID: 21951176.
      Citations: 1     Fields:    Translation:Humans
    48. Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8. PMID: 21689962.
      Citations: 31     Fields:    Translation:Humans
    49. Strutt AM, Simpson R, Jankovic J, York MK. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7. PMID: 21668586.
      Citations: 21     Fields:    Translation:Humans
    50. Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7. PMID: 21316292; PMCID: PMC3109216.
      Citations: 30     Fields:    Translation:Humans
    51. Jawaid A, Poon M, Strutt AM, Rice LK, McDowell EJ, Salamone AR, Qureshi SU, Simpson E, Appel SH, York MK, Schulz PE. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24. PMID: 20880000.
      Citations: 8     Fields:    Translation:Humans
    52. Jawaid A, Murthy SB, Wilson AM, Qureshi SU, Amro MJ, Wheaton M, Simpson E, Harati Y, Strutt AM, York MK, Schulz PE. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8. PMID: 20500116.
      Citations: 54     Fields:    Translation:Humans
    53. Hannon PM, Kuo SH, Strutt AM, York MK, Kass JS. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010 Jul; 112(6):544-7. PMID: 20444540; PMCID: PMC6474237.
      Citations: 1     Fields:    Translation:Humans
    54. Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 03; 11(3):303-11. PMID: 20433413.
      Citations: 61     Fields:    Translation:Humans
    55. Lepow L, Van Sweringen J, Strutt AM, Jawaid A, MacAdam C, Harati Y, Schulz PE, York MK. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22. PMID: 20390792.
      Citations: 6     Fields:    Translation:Humans
    56. Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, Schulz PE. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010; 29(1):28-36. PMID: 20110698.
      Citations: 3     Fields:    Translation:Humans
    57. Karmonik C, York M, Grossman R, Kakkar E, Patel K, Haykal H, King D. An image analysis pipeline for the semi-automated analysis of clinical fMRI images based on freely available software. Comput Biol Med. 2010 Mar; 40(3):279-87. PMID: 20074720.
      Citations: 2     Fields:    
    58. Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, Simpson E, Appel SH, York MK, Schulz PE. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9. PMID: 20074230.
      Citations: 37     Fields:    Translation:Humans
    59. York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71. PMID: 19767016; PMCID: PMC2783787.
      Citations: 44     Fields:    Translation:Humans
    60. Kalkonde YV, Pinto-Patarroyo GP, Goldman T, Strutt AM, York MK, Kunik ME, Schulz PE. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009; 28(2):145-52. PMID: 19690417.
      Citations: 2     Fields:    Translation:Humans
    61. Dulay MF, Levin HS, York MK, Mizrahi EM, Verma A, Goldsmith I, Grossman RG, Yoshor D. Predictors of individual visual memory decline after unilateral anterior temporal lobe resection. Neurology. 2009 May 26; 72(21):1837-42. PMID: 19470966.
      Citations: 3     Fields:    Translation:Humans
    62. Shirani P, Salamone AR, Lahijani E, York MK, Schulz PE. Lumbar puncture alleviates chorea in a patient with Huntington's disease and normal pressure hydrocephalus. Behav Neurol. 2009; 21(3):193-5. PMID: 20178144; PMCID: PMC5444282.
      Citations: 1     Fields:    Translation:Humans
    63. Dulay MF, Levin HS, York MK, Li X, Mizrahi EM, Goldsmith I, Verma A, Goldman A, Grossman RG, Yoshor D. Changes in individual and group spatial and verbal learning characteristics after anterior temporal lobectomy. Epilepsia. 2009 Jun; 50(6):1385-95. PMID: 18657174.
      Citations: 4     Fields:    Translation:Humans
    64. Strutt AM, Lai EC, Jankovic J, Atassi F, Soety EM, Levin HS, Grossman RG, York MK. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8. PMID: 18514283; PMCID: PMC2735757.
      Citations:    Fields:    Translation:Humans
    65. Dulay MF, Strutt AM, Levin HS, Jankovic J, Lai EC, Grossman RG, York MK. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63. PMID: 18806240.
      Citations: 1     Fields:    Translation:Humans
    66. York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95. PMID: 17965146.
      Citations: 48     Fields:    Translation:Humans
    67. York MK, Lai EC, Jankovic J, Macias A, Atassi F, Levin HS, Grossman RG. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866. PMID: 17624489.
      Citations: 8     Fields:    Translation:Humans
    68. Dulay MF, York MK, Soety EM, Hamilton WJ, Mizrahi EM, Goldsmith IL, Verma A, Grossman RG, Yoshor D, Armstrong DD, Levin HS. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006 Nov; 47(11):1922-30. PMID: 17116033.
      Citations: 2     Fields:    Translation:Humans
    69. McClure SM, York MK, Montague PR. The neural substrates of reward processing in humans: the modern role of FMRI. Neuroscientist. 2004 Jun; 10(3):260-8. PMID: 15155064.
      Citations: 170     Fields:    Translation:HumansAnimalsCells
    70. York MK, Rettig GM, Grossman RG, Hamilton WJ, Armstrong DD, Levin HS, Mizrahi EM. Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia. 2003 Mar; 44(3):387-98. PMID: 12614395.
      Citations: 6     Fields:    Translation:Humans
    71. York MK, Levin HS, Grossman RG, Lai EC, Krauss JK. Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003 Feb; 25(1):110-21. PMID: 12607176.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    72. York MK, Franks JJ, Henry RR, Hamilton WJ. Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychol Med. 2001 Oct; 31(7):1279-91. PMID: 11681554.
      Citations: 13     Fields:    Translation:Humans
    73. York MK, Levin HS, Grossman RG. Pallidotomy and psychological outcomes. J Neurosurg. 2001 May; 94(5):866-8. PMID: 11354429.
      Citations:    Fields:    Translation:Humans
    74. Rettig GM, York MK, Lai EC, Jankovic J, Krauss JK, Grossman RG, Levin HS. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36. PMID: 10945807; PMCID: PMC1737102.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    75. York MK, Levin HS, Grossman RG, Hamilton WJ. Neuropsychological outcome following unilateral pallidotomy. Brain. 1999 Dec; 122 ( Pt 12):2209-20. PMID: 10581217.
      Citations: 7     Fields:    Translation:Humans
    76. Shannon KM, Penn RD, Kroin JS, Adler CH, Janko KA, York M, Cox SJ. Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology. 1998 Feb; 50(2):434-8. PMID: 9484368.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    77. Griffiths HA, Wilhelm KP, Robinson MK, Wang XM, McFadden J, York M, Basketter DA. Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard. Food Chem Toxicol. 1997 Feb; 35(2):255-60. PMID: 9146738.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    78. York M, Basketter DA, Cuthbert JA, Neilson L. Skin irritation testing in man for hazard assessment--evaluation of four patch systems. Hum Exp Toxicol. 1995 Sep; 14(9):729-34. PMID: 8579884.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    YORK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (274)
    Explore
    _
    Co-Authors (31)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _